CG Oncology, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.About CGON
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
CGON Key Statistics
Stock Snapshot
As of today, CG Oncology, Inc.(CGON) shares are valued at $51.03. The company's market cap stands at 4.16B, with a P/E ratio of -25.96.
On 2026-02-16, CG Oncology, Inc.(CGON) stock moved within a range of $50.58 to $52.77. With shares now at $51.03, the stock is trading +0.9% above its intraday low and -3.3% below the session's peak.
Trading volume for CG Oncology, Inc.(CGON) stock has reached 735.89K, versus its average volume of 860.82K.
Over the past 52 weeks, CG Oncology, Inc.(CGON) stock has traded between a high of $57.88 and a low of $14.80.
Over the past 52 weeks, CG Oncology, Inc.(CGON) stock has traded between a high of $57.88 and a low of $14.80.
Analyst ratings
100%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.